Warburg Research set a €44.10 ($47.42) price target on Drägerwerk AG & Co. KGaA (ETR:DRW3 – Get Rating) in a report published on Thursday morning, Borsen Zeitung reports.
Separately, Jefferies Financial Group set a €36.00 ($38.71) target price on Drägerwerk AG & Co. KGaA in a report on Tuesday, January 17th.
Drägerwerk AG & Co. KGaA Stock Performance
ETR DRW3 opened at €42.00 ($45.16) on Thursday. The business’s 50-day moving average price is €42.17 and its 200 day moving average price is €42.55. The company has a current ratio of 1.67, a quick ratio of 0.81 and a debt-to-equity ratio of 23.87. Drägerwerk AG & Co. KGaA has a twelve month low of €38.20 ($41.08) and a twelve month high of €55.50 ($59.68). The company has a market capitalization of $361.20 million, a PE ratio of -5.97, a price-to-earnings-growth ratio of 1.24 and a beta of -0.19.
Drägerwerk AG & Co. KGaA Company Profile
Drägerwerk AG & Co KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.